Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan 19.
doi: 10.1007/s10554-026-03623-x. Online ahead of print.

Coronary atherosclerosis on AI-based plaque analysis in patients with chest pain and calcium score zero

Affiliations

Coronary atherosclerosis on AI-based plaque analysis in patients with chest pain and calcium score zero

David Molnar et al. Int J Cardiovasc Imaging. .
No abstract available

Keywords: Artificial intelligence-based quantitative computed tomography; Clinical reading; Long-term outcome; Non-obstructive coronary artery disease; Sex-differences.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The study was funded by the Finnish Foundation for Cardiovascular Research, Finnish State Research Funding, and the Research Council of Finland. Cleerly, Inc. performed the image analysis without costs and provided an unrestricted research grant for the University of Turku. Dr. Molnar’s work has been co-funded by the European Union’s Horizon Europe Framework program for research and innovation 2021-2027 under the Marie Slodowska-Curie grant agreement No. 101126611, the Swedish Medical Society, the Swedish Heart-Lung Foundation, the Swedish Heart Union and the Gothenburg Medical Society. Dr. Knuuti received consultancy fees from GE Healthcare and Synektik and speaker fees from Bayer, Lundbeck, Boehringer-Ingelheim, Pfizer and Siemens, outside of the submitted work. Dr. Bax received speaker fees from Abbott, outside of the submitted work. Dr. Saraste received consultancy fees from Astra Zeneca, Novo Nordisk and Pfizer, and speaker fees from Abbott, Astra Zeneca, BMS, Janssen, and Pfizer outside of the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

References

    1. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15(4):827–832 - DOI - PubMed
    1. Nakanishi R, Li D, Blaha MJ et al (2015) All-cause mortality by age and gender based on coronary artery calcium scores. Eur Heart J Cardiovasc Imaging. https://doi.org/10.1093/ehjci/jev328 - DOI - PubMed - PMC
    1. Polonsky TS, McClelland RL, Jorgensen NW et al (2010) Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA : J Am Med Association 303(16):1610–1616. https://doi.org/10.1001/jama.2010.461 - DOI
    1. Bell KJL, White S, Hassan O et al (2022) Evaluation of the incremental value of a coronary artery calcium score beyond traditional cardiovascular risk assessment: a systematic review and meta-analysis. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2022.1262 - DOI - PubMed - PMC
    1. Ferencik M, Mayrhofer T, Puchner SB et al (2015) Computed tomography-based high-risk coronary plaque score to predict acute coronary syndrome among patients with acute chest pain–results from the ROMICAT II trial. J Cardiovasc Comput Tomogr 9(6):538–545. https://doi.org/10.1016/j.jcct.2015.07.003 - DOI - PubMed - PMC

LinkOut - more resources